Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Sign In to gain access to subscriptions and/or personal tools.
Journal of Biomolecular Screening
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Gilbert, D.
Right arrow Articles by Lynch, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gilbert, D.
Right arrow Articles by Lynch, J. W.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Optimizing the Expression of Recombinant {alpha}β{gamma} GABAA Receptors in HEK293 Cells for High-Throughput Screening

Daniel Gilbert

Queensland Brain Institute, University of Queensland, Brisbane, Australia, School of Biomedical Sciences, University of Queensland, Brisbane, Australia

Abolghasem Esmaeili

Queensland Brain Institute, University of Queensland, Brisbane, Australia, Department of Biology, University of Isfahan, Isfahan, Iran

Joseph W. Lynch

Queensland Brain Institute, University of Queensland, Brisbane, Australia, School of Biomedical Sciences, University of Queensland, Brisbane, Australia, j.lynch{at}uq.edu.au

Despite being important clinical targets, it is not straightforward to reliably express recombinant trimeric {alpha}β{gamma} GABA-A receptors (GABAARs) for high-throughput screening. This study therefore sought to devise a simple and reliable means of transiently expressing {alpha}1β1{gamma}1 and {alpha}1β1{gamma}2 GABAARs in HEK293 cells. Expression efficiencies resulting from 5 different transfection strategies were assessed by flow cytometry and pharmacological analysis using an anion-sensitive yellow fluorescent protein-based assay. PolyFectTM and EffecteneTM, employed according to the manufacturers' instructions, conferred the strongest and most reliable expression of trimeric {alpha}β{gamma} GABAARs. Functional analysis via the yellow fluorescent protein assay revealed dramatic differences in the pharmacological properties of {gamma}1- and {gamma}2-containing receptors, consistent with previous electrophysiological characterizations. The authors conclude that this method of expressing and screening recombinant GABAARs provides an effective means of discovering novel GABAAR modulators for use as therapeutic lead compounds and pharmacological probes. (Journal of Biomolecular Screening 2009:86-91)

Key Words: chloride channel • drug discovery • yellow fluorescent protein • inhibitory • neurotransmission

Journal of Biomolecular Screening, Vol. 14, No. 1, 86-91 (2009)
DOI: 10.1177/1087057108328017


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
J Biomol ScreenHome page
D. F. Gilbert, T. Meinhof, R. Pepperkok, and H. Runz
DetecTiff(C): A Novel Image Analysis Routine for High-Content Screening Microscopy
J Biomol Screen, September 1, 2009; 14(8): 944 - 955.
[Abstract] [PDF]